Annual report [Section 13 and 15(d), not S-K Item 405]

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest	Total
Balances (in shares) at Jun. 30, 2022	156,644,000
Balance at Jun. 30, 2022	$ 1,566	$ 652,467	$ 1,122,937	$ (75,200)	$ (759)	$ 1,701,011
Reclassification of cumulative translation adjustment for Eminence to non-operating income				152	(33)	119
Elimination of noncontrolling equity interest from sale of Eminence					613	613
Net earnings, including noncontrolling interest			285,263		$ 179	285,442
Other comprehensive income (loss) before reclassification				8,984		8,984
Other comprehensive income (loss)						$ 9,103
Share repurchases (in shares)	(222,000)					(222,000)
Share repurchases	$ (2)		(19,560)			$ (19,562)
Common stock issued for exercise of options (in shares)	1,083,000					1,578,000
Common stock issued for exercise of options	$ 10	24,942	(22,163)			$ 2,789
Common stock issued for restricted stock awards	$ 1	(1)	(6,731)			(6,731)
Common stock issued for restricted stock awards (in shares)	63,000
Cash dividends			(50,285)			(50,285)
Stock-based compensation expense		38,315				38,315
Common stock issued to employee stock purchase plan (in shares)	74,000
Common stock issued to employee stock purchase plan	$ 1	4,905				4,906
Employee stock purchase plan expense		915				915
Balance at Jun. 30, 2023	$ 1,576	721,543	1,309,461	(66,064)		1,966,516
Balances (in shares) at Jun. 30, 2023	157,642,000
Net earnings, including noncontrolling interest			168,105			168,105
Other comprehensive income (loss) before reclassification				(12,252)		(12,252)
Other comprehensive income (loss)						$ (12,252)
Share repurchases (in shares)	(1,397,000)					(1,397,471)
Share repurchases	$ (14)		(80,028)			$ (80,042)
Common stock issued for exercise of options (in shares)	1,811,000					2,240,000
Common stock issued for exercise of options	$ 18	56,409	(16,534)			$ 39,893
Common stock issued for restricted stock awards	$ 1	(1)	(5,338)			(5,338)
Common stock issued for restricted stock awards (in shares)	91,000
Cash dividends			(50,419)			(50,419)
Stock-based compensation expense		37,136				37,136
Common stock issued to employee stock purchase plan (in shares)	69,000
Common stock issued to employee stock purchase plan	$ 1	4,344				4,345
Employee stock purchase plan expense		906				906
Balance at Jun. 30, 2024	$ 1,582	820,337	1,325,247	(78,316)		$ 2,068,850
Balances (in shares) at Jun. 30, 2024	158,216,000					158,216,258
Net earnings, including noncontrolling interest			73,400			$ 73,400
Other comprehensive income (loss)				18,436		$ 18,436
Share repurchases (in shares)	(4,550,000)					(4,550,195)
Share repurchases	$ (45)	(1,807)	(275,686)			$ (277,538)
Common stock issued for exercise of options (in shares)	1,138,000					1,209,000
Common stock issued for exercise of options	$ 11	47,258	(2,358)			$ 44,911
Common stock issued for restricted stock awards	$ 1	(1)	(4,163)			(4,163)
Common stock issued for restricted stock awards (in shares)	90,000
Cash dividends			(50,391)			(50,391)
Stock-based compensation expense		40,008				40,008
Common stock issued to employee stock purchase plan (in shares)	78,000
Common stock issued to employee stock purchase plan	$ 1	4,469				4,470
Employee stock purchase plan expense		825				825
Balance at Jun. 30, 2025	$ 1,550	$ 911,089	$ 1,066,049	$ (59,880)		$ 1,918,808
Balances (in shares) at Jun. 30, 2025	154,972,000					154,972,196